NR566 | NR566 Advanced Pharmacology for Care
of the Family Wk 1 Final Exam v2 | Questions with
Correct Answers and Expert Explanation for Each
Question | Chamberlain
1. A patient is taking a drug that is a known substrate of the CYP3A4 enzyme. If the
patient starts taking a second drug that is a potent CYP3A4 inhibitor, what is the most
likely pharmacological outcome?
A. No change in the metabolism of the first drug
B. Decreased plasma levels and reduced efficacy of the first drug
C. Rapid excretion of the first drug through the kidneys
D. Increased plasma levels and potential toxicity of the first drug
Correct Answer: D
Expert Explanation: Inhibition of the CYP450 enzyme system reduces the rate of
metabolism for drugs that are substrates of that specific enzyme. This reduction in
metabolism leads to higher concentrations of the drug remaining in the bloodstream
for a longer duration. Consequently, the patient is at a significantly higher risk for
drug toxicity and adverse reactions.
2. Which pharmacokinetic process is primarily affected by a patient’s serum albumin
levels?
A. Absorption
,B. Metabolism
C. Distribution
D. Excretion
Correct Answer: C
Expert Explanation: Distribution refers to the transport of a drug by the
bloodstream to its site of action. Many drugs bind to plasma proteins like albumin,
and only the ‘free’ or unbound drug is pharmacologically active. If albumin levels are
low, there is less protein for the drug to bind to, which increases the amount of free
drug available in the body.
3. According to the DEA, which drug schedule contains substances with a high
potential for abuse, currently accepted medical use in the US, and may lead to severe
psychological or physical dependence?
A. Schedule I
B. Schedule III
C. Schedule II
D. Schedule IV
Correct Answer: C
,Expert Explanation: Schedule II drugs are classified as having a high potential for
abuse but are recognized for medical treatment. Examples include morphine,
oxycodone, and amphetamines. Unlike Schedule I drugs, they have a legitimate
medical use but require strict prescribing regulations due to the risk of severe
dependence.
4. When prescribing for an elderly patient, the provider understands that which
physiological change typically leads to a longer half-life of lipid-soluble drugs?
A. Increased total body water
B. Decreased body fat
C. Increased hepatic blood flow
D. Increased percentage of body fat
Correct Answer: D
Expert Explanation: As individuals age, they generally experience an increase in
body fat and a decrease in lean muscle mass and total body water. Lipid-soluble
drugs distribute more extensively into adipose tissue, which acts as a reservoir. This
increased volume of distribution results in a prolonged half-life and slower
elimination from the body.
5. What is the primary site of the ‘First-Pass Effect’ in pharmacology?
A. The liver
, B. The stomach
C. The kidneys
D. The small intestine
Correct Answer: A
Expert Explanation: The first-pass effect occurs when an orally administered drug
is absorbed from the GI tract and enters the portal circulation. Before reaching the
systemic circulation, the drug passes through the liver, where it may be extensively
metabolized. This process can significantly reduce the bioavailability of the drug
before it ever reaches the target tissues.
6. A drug that binds to a receptor and produces a maximal biological response is
referred to as a(n):
A. Antagonist
B. Partial Agonist
C. Full Agonist
D. Inverse Agonist
Correct Answer: C
Expert Explanation: A full agonist is a drug that binds to a specific receptor and
triggers a full pharmacological response. It mimics the action of endogenous ligands
of the Family Wk 1 Final Exam v2 | Questions with
Correct Answers and Expert Explanation for Each
Question | Chamberlain
1. A patient is taking a drug that is a known substrate of the CYP3A4 enzyme. If the
patient starts taking a second drug that is a potent CYP3A4 inhibitor, what is the most
likely pharmacological outcome?
A. No change in the metabolism of the first drug
B. Decreased plasma levels and reduced efficacy of the first drug
C. Rapid excretion of the first drug through the kidneys
D. Increased plasma levels and potential toxicity of the first drug
Correct Answer: D
Expert Explanation: Inhibition of the CYP450 enzyme system reduces the rate of
metabolism for drugs that are substrates of that specific enzyme. This reduction in
metabolism leads to higher concentrations of the drug remaining in the bloodstream
for a longer duration. Consequently, the patient is at a significantly higher risk for
drug toxicity and adverse reactions.
2. Which pharmacokinetic process is primarily affected by a patient’s serum albumin
levels?
A. Absorption
,B. Metabolism
C. Distribution
D. Excretion
Correct Answer: C
Expert Explanation: Distribution refers to the transport of a drug by the
bloodstream to its site of action. Many drugs bind to plasma proteins like albumin,
and only the ‘free’ or unbound drug is pharmacologically active. If albumin levels are
low, there is less protein for the drug to bind to, which increases the amount of free
drug available in the body.
3. According to the DEA, which drug schedule contains substances with a high
potential for abuse, currently accepted medical use in the US, and may lead to severe
psychological or physical dependence?
A. Schedule I
B. Schedule III
C. Schedule II
D. Schedule IV
Correct Answer: C
,Expert Explanation: Schedule II drugs are classified as having a high potential for
abuse but are recognized for medical treatment. Examples include morphine,
oxycodone, and amphetamines. Unlike Schedule I drugs, they have a legitimate
medical use but require strict prescribing regulations due to the risk of severe
dependence.
4. When prescribing for an elderly patient, the provider understands that which
physiological change typically leads to a longer half-life of lipid-soluble drugs?
A. Increased total body water
B. Decreased body fat
C. Increased hepatic blood flow
D. Increased percentage of body fat
Correct Answer: D
Expert Explanation: As individuals age, they generally experience an increase in
body fat and a decrease in lean muscle mass and total body water. Lipid-soluble
drugs distribute more extensively into adipose tissue, which acts as a reservoir. This
increased volume of distribution results in a prolonged half-life and slower
elimination from the body.
5. What is the primary site of the ‘First-Pass Effect’ in pharmacology?
A. The liver
, B. The stomach
C. The kidneys
D. The small intestine
Correct Answer: A
Expert Explanation: The first-pass effect occurs when an orally administered drug
is absorbed from the GI tract and enters the portal circulation. Before reaching the
systemic circulation, the drug passes through the liver, where it may be extensively
metabolized. This process can significantly reduce the bioavailability of the drug
before it ever reaches the target tissues.
6. A drug that binds to a receptor and produces a maximal biological response is
referred to as a(n):
A. Antagonist
B. Partial Agonist
C. Full Agonist
D. Inverse Agonist
Correct Answer: C
Expert Explanation: A full agonist is a drug that binds to a specific receptor and
triggers a full pharmacological response. It mimics the action of endogenous ligands
